Global PD-1 and PD-L1 Monoclonal Antibody Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Monoclonal Antibody by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Monoclonal Antibody by Country/Region, 2017, 2022 & 2028

2.2 PD-1 and PD-L1 Monoclonal Antibody Segment by Type

2.2.1 PD-1

2.2.2 PD-L1

2.3 PD-1 and PD-L1 Monoclonal Antibody Sales by Type

2.3.1 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)

2.3.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue and Market Share by Type (2017-2022)

2.3.3 Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Type (2017-2022)

2.4 PD-1 and PD-L1 Monoclonal Antibody Segment by Application

2.4.1 Lung Cancer

2.4.2 Liver Cancer

2.4.3 Esophageal Cancer

2.4.4 Gastric Cancer

2.4.5 Nasopharyngeal Carcinoma

2.4.6 Head and Neck Cancer

2.4.7 Other

2.5 PD-1 and PD-L1 Monoclonal Antibody Sales by Application

2.5.1 Global PD-1 and PD-L1 Monoclonal Antibody Sale Market Share by Application (2017-2022)

2.5.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue and Market Share by Application (2017-2022)

2.5.3 Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Application (2017-2022)

3 Global PD-1 and PD-L1 Monoclonal Antibody by Company

3.1 Global PD-1 and PD-L1 Monoclonal Antibody Breakdown Data by Company

3.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Annual Sales by Company (2020-2022)

3.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Company (2020-2022)

3.2 Global PD-1 and PD-L1 Monoclonal Antibody Annual Revenue by Company (2020-2022)

3.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Company (2020-2022)

3.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Company (2020-2022)

3.3 Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Company

3.4 Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Location Distribution

3.4.2 Players PD-1 and PD-L1 Monoclonal Antibody Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for PD-1 and PD-L1 Monoclonal Antibody by Geographic Region

4.1 World Historic PD-1 and PD-L1 Monoclonal Antibody Market Size by Geographic Region (2017-2022)

4.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Annual Sales by Geographic Region (2017-2022)

4.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Annual Revenue by Geographic Region

4.2 World Historic PD-1 and PD-L1 Monoclonal Antibody Market Size by Country/Region (2017-2022)

4.2.1 Global PD-1 and PD-L1 Monoclonal Antibody Annual Sales by Country/Region (2017-2022)

4.2.2 Global PD-1 and PD-L1 Monoclonal Antibody Annual Revenue by Country/Region

4.3 Americas PD-1 and PD-L1 Monoclonal Antibody Sales Growth

4.4 APAC PD-1 and PD-L1 Monoclonal Antibody Sales Growth

4.5 Europe PD-1 and PD-L1 Monoclonal Antibody Sales Growth

4.6 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Growth

5 Americas

5.1 Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Country

5.1.1 Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022)

5.1.2 Americas PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022)

5.2 Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Type

5.3 Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Region

6.1.1 APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022)

6.1.2 APAC PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022)

6.2 APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Type

6.3 APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe PD-1 and PD-L1 Monoclonal Antibody by Country

7.1.1 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022)

7.1.2 Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022)

7.2 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type

7.3 Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody by Country

8.1.1 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022)

8.1.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022)

8.2 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type

8.3 Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Monoclonal Antibody

10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody

10.4 Industry Chain Structure of PD-1 and PD-L1 Monoclonal Antibody

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 PD-1 and PD-L1 Monoclonal Antibody Distributors

11.3 PD-1 and PD-L1 Monoclonal Antibody Customer

12 World Forecast Review for PD-1 and PD-L1 Monoclonal Antibody by Geographic Region

12.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size Forecast by Region

12.1.1 Global PD-1 and PD-L1 Monoclonal Antibody Forecast by Region (2023-2028)

12.1.2 Global PD-1 and PD-L1 Monoclonal Antibody Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global PD-1 and PD-L1 Monoclonal Antibody Forecast by Type

12.7 Global PD-1 and PD-L1 Monoclonal Antibody Forecast by Application

13 Key Players Analysis

13.1 Merk

13.1.1 Merk Company Information

13.1.2 Merk PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merk Main Business Overview

13.1.5 Merk Latest Developments

13.2 Bristol-Myers Squibb Company

13.2.1 Bristol-Myers Squibb Company Company Information

13.2.2 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bristol-Myers Squibb Company Main Business Overview

13.2.5 Bristol-Myers Squibb Company Latest Developments

13.3 Roche

13.3.1 Roche Company Information

13.3.2 Roche PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Main Business Overview

13.3.5 Roche Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Junshi Biosciences

13.6.1 Junshi Biosciences Company Information

13.6.2 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Junshi Biosciences Main Business Overview

13.6.5 Junshi Biosciences Latest Developments

13.7 Innovent

13.7.1 Innovent Company Information

13.7.2 Innovent PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Innovent Main Business Overview

13.7.5 Innovent Latest Developments

13.8 Hengrui

13.8.1 Hengrui Company Information

13.8.2 Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hengrui Main Business Overview

13.8.5 Hengrui Latest Developments

13.9 BeiGene

13.9.1 BeiGene Company Information

13.9.2 BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 BeiGene Main Business Overview

13.9.5 BeiGene Latest Developments

13.10 Alphamab Oncology

13.10.1 Alphamab Oncology Company Information

13.10.2 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Alphamab Oncology Main Business Overview

13.10.5 Alphamab Oncology Latest Developments

13.11 Cstone

13.11.1 Cstone Company Information

13.11.2 Cstone PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Cstone Main Business Overview

13.11.5 Cstone Latest Developments

13.12 Akeso

13.12.1 Akeso Company Information

13.12.2 Akeso PD-1 and PD-L1 Monoclonal Antibody Product Offered

13.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Akeso Main Business Overview

13.12.5 Akeso Latest Developments

14 Research Findings and Conclusion

Table 1. PD-1 and PD-L1 Monoclonal Antibody Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. PD-1 and PD-L1 Monoclonal Antibody Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of PD-1

Table 4. Major Players of PD-L1

Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)

Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)

Table 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Type (2017-2022) & ($ million)

Table 8. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2017-2022)

Table 9. Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)

Table 11. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)

Table 12. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Application (2017-2022)

Table 13. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application (2017-2022)

Table 14. Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Company (2020-2022) & (Units)

Table 16. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Company (2020-2022)

Table 17. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Company (2020-2022) ($ Millions)

Table 18. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Company (2020-2022)

Table 19. Global PD-1 and PD-L1 Monoclonal Antibody Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Producing Area Distribution and Sales Area

Table 21. Players PD-1 and PD-L1 Monoclonal Antibody Products Offered

Table 22. PD-1 and PD-L1 Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Geographic Region (2017-2022)

Table 27. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Country/Region (2017-2022) & (Units)

Table 30. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country/Region (2017-2022)

Table 31. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)

Table 34. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022)

Table 35. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022)

Table 37. Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)

Table 38. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)

Table 39. Americas PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)

Table 40. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)

Table 41. APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2017-2022) & (Units)

Table 42. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2022)

Table 43. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Region (2017-2022)

Table 45. APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)

Table 46. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)

Table 47. APAC PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)

Table 48. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)

Table 49. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)

Table 50. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022)

Table 51. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022)

Table 53. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)

Table 54. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)

Table 55. Europe PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)

Table 56. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Monoclonal Antibody

Table 66. Key Market Challenges & Risks of PD-1 and PD-L1 Monoclonal Antibody

Table 67. Key Industry Trends of PD-1 and PD-L1 Monoclonal Antibody

Table 68. PD-1 and PD-L1 Monoclonal Antibody Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. PD-1 and PD-L1 Monoclonal Antibody Distributors List

Table 71. PD-1 and PD-L1 Monoclonal Antibody Customer List

Table 72. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Forecast by Region

Table 74. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Type (2023-2028)

Table 86. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global PD-1 and PD-L1 Monoclonal Antibody Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share Forecast by Application (2023-2028)

Table 90. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share Forecast by Application (2023-2028)

Table 92. Merk Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 93. Merk PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 94. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Merk Main Business

Table 96. Merk Latest Developments

Table 97. Bristol-Myers Squibb Company Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 98. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 99. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Bristol-Myers Squibb Company Main Business

Table 101. Bristol-Myers Squibb Company Latest Developments

Table 102. Roche Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 103. Roche PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 104. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Roche Main Business

Table 106. Roche Latest Developments

Table 107. Pfizer Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 108. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 109. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Pfizer Main Business

Table 111. Pfizer Latest Developments

Table 112. AstraZeneca Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 113. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 114. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. AstraZeneca Main Business

Table 116. AstraZeneca Latest Developments

Table 117. Junshi Biosciences Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 118. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 119. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Junshi Biosciences Main Business

Table 121. Junshi Biosciences Latest Developments

Table 122. Innovent Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 123. Innovent PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 124. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Innovent Main Business

Table 126. Innovent Latest Developments

Table 127. Hengrui Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 128. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 129. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Hengrui Main Business

Table 131. Hengrui Latest Developments

Table 132. BeiGene Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 133. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 134. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. BeiGene Main Business

Table 136. BeiGene Latest Developments

Table 137. Alphamab Oncology Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 138. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 139. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Alphamab Oncology Main Business

Table 141. Alphamab Oncology Latest Developments

Table 142. Cstone Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 143. Cstone PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 144. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Cstone Main Business

Table 146. Cstone Latest Developments

Table 147. Akeso Basic Information, PD-1 and PD-L1 Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

Table 148. Akeso PD-1 and PD-L1 Monoclonal Antibody Product Offered

Table 149. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Akeso Main Business

Table 151. Akeso Latest Developments

List of Figures

Figure 1. Picture of PD-1 and PD-L1 Monoclonal Antibody

Figure 2. PD-1 and PD-L1 Monoclonal Antibody Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Growth Rate 2017-2028 (Units)

Figure 7. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. PD-1 and PD-L1 Monoclonal Antibody Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of PD-1

Figure 10. Product Picture of PD-L1

Figure 11. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Type in 2021

Figure 12. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Type (2017-2022)

Figure 13. PD-1 and PD-L1 Monoclonal Antibody Consumed in Lung Cancer

Figure 14. Global PD-1 and PD-L1 Monoclonal Antibody Market: Lung Cancer (2017-2022) & (Units)

Figure 15. PD-1 and PD-L1 Monoclonal Antibody Consumed in Liver Cancer

Figure 16. Global PD-1 and PD-L1 Monoclonal Antibody Market: Liver Cancer (2017-2022) & (Units)

Figure 17. PD-1 and PD-L1 Monoclonal Antibody Consumed in Esophageal Cancer

Figure 18. Global PD-1 and PD-L1 Monoclonal Antibody Market: Esophageal Cancer (2017-2022) & (Units)

Figure 19. PD-1 and PD-L1 Monoclonal Antibody Consumed in Gastric Cancer

Figure 20. Global PD-1 and PD-L1 Monoclonal Antibody Market: Gastric Cancer (2017-2022) & (Units)

Figure 21. PD-1 and PD-L1 Monoclonal Antibody Consumed in Nasopharyngeal Carcinoma

Figure 22. Global PD-1 and PD-L1 Monoclonal Antibody Market: Nasopharyngeal Carcinoma (2017-2022) & (Units)

Figure 23. PD-1 and PD-L1 Monoclonal Antibody Consumed in Head and Neck Cancer

Figure 24. Global PD-1 and PD-L1 Monoclonal Antibody Market: Head and Neck Cancer (2017-2022) & (Units)

Figure 25. PD-1 and PD-L1 Monoclonal Antibody Consumed in Other

Figure 26. Global PD-1 and PD-L1 Monoclonal Antibody Market: Other (2017-2022) & (Units)

Figure 27. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Application (2017-2022)

Figure 28. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Application in 2021

Figure 29. PD-1 and PD-L1 Monoclonal Antibody Revenue Market by Company in 2021 ($ Million)

Figure 30. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Company in 2021

Figure 31. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Geographic Region in 2021

Figure 33. Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region (2017-2022)

Figure 34. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country/Region in 2021

Figure 35. Americas PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2022 (Units)

Figure 36. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2022 ($ Millions)

Figure 37. APAC PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2022 (Units)

Figure 38. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2022 ($ Millions)

Figure 39. Europe PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2022 (Units)

Figure 40. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales 2017-2022 (Units)

Figure 42. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue 2017-2022 ($ Millions)

Figure 43. Americas PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2021

Figure 44. Americas PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country in 2021

Figure 45. United States PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Region in 2021

Figure 50. APAC PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Regions in 2021

Figure 51. China PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 55. India PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2021

Figure 58. Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country in 2021

Figure 59. Germany PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 60. France PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share by Country in 2021

Figure 65. Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share by Country in 2021

Figure 66. Egypt PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country PD-1 and PD-L1 Monoclonal Antibody Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Monoclonal Antibody in 2021

Figure 72. Manufacturing Process Analysis of PD-1 and PD-L1 Monoclonal Antibody

Figure 73. Industry Chain Structure of PD-1 and PD-L1 Monoclonal Antibody

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles